'Last Sunday (August 30, 2015) an article about the new cholesterol-lowering drugs appeared in the New York Times (NYT).
The article can be read here: (Editor's Note: The original article is accessed after clicking "Read more" and then clicking the title below on that page)
New Alternatives to Statins Add to a Quandary on Cholesterol
The article focused on the side effects of statin drugs and it questioned if doctors will prescribe the new drugs even though they are very expensive. After reading it in the NYT, my friend and colleague, Dr. Ira Goodman, called me and suggested we write a letter to the editor. Of course, the NYT did not accept our letter, but I thought it would make an interesting blog post.'